Mostrar el registro sencillo del ítem

Artículo

dc.creatorGiráldez Pérez, Rosa Maríaes
dc.creatorGrueso Molina, Elia Maríaes
dc.creatorJiménez Aguayo, Raqueles
dc.creatorCarbonero, Alfonsoes
dc.creatorGonzález Bravo, Marinaes
dc.creatorKuliszewska, Edytaes
dc.creatorPrado Gotor, Rafaeles
dc.date.accessioned2023-05-15T17:25:31Z
dc.date.available2023-05-15T17:25:31Z
dc.date.issued2022
dc.identifier.citationGiráldez Pérez, R.M., Grueso Molina, E.M., Jiménez Aguayo, R., Carbonero, A., González Bravo, M., Kuliszewska, E. y Prado Gotor, R. (2022). Use of Nanoparticles to Prevent Resistance to Antibiotics—Synthesis and Characterization of Gold Nanosystems Based on Tetracycline. Pharmaceutics, 14 (9). https://doi.org/10.3390/pharmaceutics14091941.
dc.identifier.issn1999-4923es
dc.identifier.urihttps://hdl.handle.net/11441/146040
dc.description.abstractAntimicrobial resistance (AMR) is a serious public health problem worldwide which, according to the World Health Organization (WHO), requires research into new and more effective drugs. In this work, both gold nanoparticles covered with 16-3-16 cationic gemini surfactant (Au@16-3-16) and DNA/tetracycline (DNA/TC) intercalated complexes were prepared to effectively transport tetracycline (TC). Synthesis of the Au@16-3-16 precursor was carried out by using trihydrated gold, adding sodium borohydride as a reducing agent and the gemini surfactant 16-3-16 as stabilizing agent. Circular dichroism and atomic force microscopy techniques were then used to ascertain the optimal R range of the relationship between the concentrations of Au@16-3-16 and the DNA/TC complex (R = CAu@16-3-16/CDNA) that allow the obtainment of stable and compact nanosystems, these characteristics being fundamental for their use as antibiotic transporters. Stability studies over time were carried out for distinct selected Au@16-3-16 and Au@16-3-16/DNA-TC nanoformulations using the ultraviolet–visible spectrophotometry technique, checking their stability for at least one month. In addition, in order to know the charge and size distribution of the nanocomplexes, DLS and zeta potential measurements were performed in the solution. The results showed that the characterized nanosystems were highly charged, stable and of a reduced size (<100 nm) that allows them to cross bacterial membranes effectively (>1 µm). Once the different physicochemical characteristics of the gold nanosystems were measured, Au@16-3-16 and Au@16-3-16/DNA-TC were tested on Escherichia coli and Staphylococcus aureus to study their antibacterial properties and internalization capacity in microbes. Differences in the interaction of the precursors and the compacted nanosystems generated were observed in Gram-positive and Gram-negative bacteria, possibly due to membrane damage or electrostatic interaction with internalization by endocytosis. In the internalization experiments, depending on the treatment application time, the greatest bacterial destruction was observed for all nanoformulations explored at 18 h of incubation. Importantly, the results obtained demonstrate that both new nanosystems based on TC and Au@16-3-16 precursors have optimal antimicrobial properties and would be beneficial for use in patients, avoiding possible side effects.es
dc.description.sponsorshipJunta de Andalucía FQM-386es
dc.description.sponsorshipUniversidad Pablo de Olavide 00001297es
dc.description.sponsorshipUniversidad de Sevilla 00000274es
dc.formatapplication/pdfes
dc.format.extent30 p.es
dc.language.isoenges
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)es
dc.relation.ispartofPharmaceutics, 14 (9).
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAntibiotic resistancees
dc.subjectDNAes
dc.subjectGemini surfactantes
dc.subjectGold nanoparticleses
dc.subjectTetracyclinees
dc.titleUse of Nanoparticles to Prevent Resistance to Antibiotics—Synthesis and Characterization of Gold Nanosystems Based on Tetracyclinees
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Química Físicaes
dc.relation.projectIDFQM-386es
dc.relation.projectID00001297es
dc.relation.projectID00000274es
dc.relation.publisherversionhttps://doi.org/10.3390/pharmaceutics14091941es
dc.identifier.doi10.3390/pharmaceutics14091941es
dc.journaltitlePharmaceuticses
dc.publication.volumen14es
dc.publication.issue9es
dc.contributor.funderJunta de Andalucíaes
dc.contributor.funderUniversidad Pablo de Olavidees
dc.contributor.funderUniversidad de Sevillaes

FicherosTamañoFormatoVerDescripción
Use of Nanoparticles to Prevent.pdf5.736MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Atribución 4.0 Internacional